1 llowed by benign, chronic cutaneous lesions (verruga peruana).

2 receptors was observed in the endothelium of verruga peruana.

3 illary angiomatosis, bacillary peliosis, and verruga peruana.

4 .3%; P <.001), and skin lesions described as verruga peruana (26.8% vs. 4.9%; P<.001).

5  situ hybridization of clinical specimens of verruga peruana for the angiogenesis factors vascular en

6  a blood sample of a patient presenting with verruga peruana in the Ancash region of Peru.

7                                              Verruga peruana is a clinical syndrome caused by the bac

8 ngly, the major source of VEGF production in verruga peruana is the overlying epidermis.

9 nella serum from a patient with the chronic, verruga peruana phase of bartonellosis.

10  bacilliformis, the agent of Oroya fever and verruga peruana, produces a proteinaceous mitogen for hu

11                           The attack rate of verruga peruana was 17.6%.